Decreases in the neurotransmitter levels in the cholinergic synapses within certain regions of the brain are caused by acetylcholine and butyrylcholine hydrolysis, caused by AChE and BChE; therefore, their inhibition by these compounds is a suitable therapy for Alzheimer’s disease [40]. Here, BCHE is linked to Alzheimer disease.